Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2389 3)

Pdp (68071 2389 3)
Packaging label for Atorvastatin Calcium 10 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a count of 30 film-coated tablets, oval-shaped white to off-white, debossed with 'FF1' on one side. The label includes barcode, lot, serial number, manufacturer information, and storage instructions.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

Figure (Atorvastatin Calcium Figure 1)
A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, and the dashed line represents Placebo. The graph includes a hazard ratio (HR=0.64 with 95% confidence interval 0.50-0.83) and a p-value of 0.0005, indicating statistical analysis between the groups over approximately 3.5 years.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
A Kaplan-Meier survival curve showing cumulative hazard percentage over time up to 5 years. It compares placebo (dotted line) and atorvastatin (solid line) groups in time to first primary endpoint, indicating lower cumulative hazard with atorvastatin. Statistical data includes hazard ratio 0.63 (0.48-0.83) and p-value 0.001.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years for Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical Structure (Atorvastatin Calcium Structure)
Chemical structure of atorvastatin calcium dihydrate, showing two atorvastatin molecules complexed with calcium ions and three water molecules per unit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.